How HHS efforts to increase competition could hurt patients.
Thomas E. Menighan, BSPharm, MBA, FAPhA
Advertisement
Articles by Thomas E. Menighan, BSPharm, MBA, FAPhA
Advertisement
Latest Updated Articles
Lower Drug Prices Aren’t Worth Higher Health RisksPublished: February 21st 2019 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Trump Administration Lays Out Great Healthcare Plan for Lower Patient Costs
2
Fremanezumab Reduces Monthly Migraine Days for Pediatric Patients
3
Pennsylvania Pharmacy Association: Promoting the Profession to Enhance Patient Care
4
Strong Pharmacist Engagement Helps Patients Effectively Use OTC Products
5